New Haven Pharmaceuticals, Inc. — Form D
New Haven Pharmaceuticals, Inc. of NORTH HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-17. The offering totals $1.3M, of which $602K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-08-17
- Form: D
- Accession: 0001558788-16-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $602K
- Remaining: $700K
- Investors: 3
- Date of first sale: 2016-08-01
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-269056
Issuer
- Name: New Haven Pharmaceuticals, Inc.
- CIK: 0001558788
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 116 WASHINGTON AVENUE, NORTH HAVEN, CT, 06473
- Phone: 203-676-3676
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Larry H Dillaha | Director | North Haven, CT |
| Christopher H Ecklund | Director | North Haven, CT |
| Patrick H Fourteau | Director | North Haven, CT |
| Harry H Penner, Jr. | Director | New Haven, CT |
| William H Sessa | Director | North Haven, CT |
| Theodore H Stanley | Director | North Haven, CT |
| Daniel H Wagner | Director | North Haven, CT |
| Patrick H Fourteau | Executive Officer | North Haven, CT |
| Harry H Penner, Jr. | Executive Officer | New Haven, CT |
| Daniel Wagner | Director | Branford, CT |
| Larry Dillaha | Director | San Diego, CA |
| Scott Kozak | Promoter | Denver, CO |
| William Sessa | Director | San Diego, CA |
| Harry Penner, Jr. | Director | New Haven, CT |
| Harry Penner, Jr. | Executive Officer | New Haven, CT |
| Harry Penner, Jr. | Promoter | New Haven, CT |
| Patrick Fourteau | Director | New Haven, CT |
| Patrick Fourteau | Executive Officer | New Haven, CT |
| Patrick Fourteau | Promoter | New Haven, CT |
| Nancy Motola | Executive Officer | New Haven, CT |
| Rob Sterling | Promoter | New Haven, CT |
Other filings by this issuer (2)
More